CeGaT, a global provider of sequencing services for research, clinical trials, and human genetic diagnostics, is the first provider in Germany that has equipped its sequencing laboratory with the PacBio system. The Single Molecule Real-Time (SMRT) technology behind it allows the generation of HiFi reads with exceptional accuracy and length. Using this technology, CeGaT now offers full-length sequencing of the 16S rRNA gene, including all variable regions. Thus, microbial taxa can be determined accurately.

The Tübingen-based company makes state-of-the-art sequencing technologies available to all life scientists. With the implementation of Full-Length 16S Sequencing into its portfolio, CeGaT now offers sequencing of the entire 16S rRNA gene to determine taxonomic distribution in bacterial communities, such as the gut microbiome.

Dr. Jiri Ködding, Director Operations, sees the extension in line with the corporate mission: "At CeGaT, we are committed to helping scientists realize their research projects. Therefore, we provide a wide range of sequencing solutions. With Full-Length 16S Sequencing, we have expanded our portfolio with another high-class sequencing service that adds even more depth and quality to the generated genetic data."

The full-length gene can now be sequenced

The highly conserved 16S rRNA gene is approximately 1.500 bp long and consists of nine hypervariable regions (V1 – V9) that differ between different bacteria. Using PacBio single molecule real-time (SMRT) technology, the entire 16S rRNA gene is sequenced. The technology enables precise long-read sequencing (HiFi reads) using circular consensus sequencing (CCS) mode. As a result, the full-length gene can now be analyzed at CeGaT.

CeGaT’s Full-Length 16S Sequencing is featured by the following:

  • fast turnaround times and the highest sequencing accuracy
  • analysis of the complete 16S rRNA gene (V1-V9 regions)
  • HiFi long reads of approx. 1,500 bp
  • simultaneous analysis of multiple samples

 

 

Über die CeGaT GmbH

CeGaT GmbH, founded in Tübingen, Germany, in 2009, is a global provider of genetic analyses for a wide range of medical, research, and pharmaceutical applications.

The company combines the latest sequencing technology with its many years of medical expertise – dedicated to identifying the genetic cause of disease and supporting patient care. For research and the pharmaceutical industry, CeGaT offers a broad portfolio of sequencing services and tumor analyses. CeGaT generates the data basis for clinical studies and medical innovations, driving science forward with its own findings. The owner-managed company stands for independence, extensive personal customer service, and premium quality. CeGaT’s laboratory is accredited according to CAP/CLIA, DIN EN ISO 15189, and DIN EN ISO 17025 and thus meets the highest international standards. To obtain first-class results, all processes are carried out in-house under scientific supervision.

Firmenkontakt und Herausgeber der Meldung:

CeGaT GmbH
Paul-Ehrlich-Str. 23
72076 Tübingen
Telefon: +49 7071 56544 260
http://www.cegat.com

Ansprechpartner:
Christfried Dornis
Marketing & Communication
Telefon: +49 (7071) 56544-261
E-Mail: christfried.dornis@cegat.de
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel